Article Type
Changed
Wed, 12/05/2018 - 13:45

From GAP 2018, Lorenzo Norris, MD, welcome Ashwin Patkar, MD, to discuss the opioid epidemic and how North Carolina is approaching it systemically. And later, Dr. RK knows that some of your patients are blue this time of year, she joins us to talk about what that is and what you can do about it.

In an evidence-based review, Dr. Patkar overviews the issue and includes dosages and references for FDA-approved buprenophine and burprenorphine/naloxone formulation. Click here to read that review.
Amazon Alexa
Apple Podcasts
Google Podcasts  ​​​​​
Spotify

Publications
Topics
Sections

From GAP 2018, Lorenzo Norris, MD, welcome Ashwin Patkar, MD, to discuss the opioid epidemic and how North Carolina is approaching it systemically. And later, Dr. RK knows that some of your patients are blue this time of year, she joins us to talk about what that is and what you can do about it.

In an evidence-based review, Dr. Patkar overviews the issue and includes dosages and references for FDA-approved buprenophine and burprenorphine/naloxone formulation. Click here to read that review.
Amazon Alexa
Apple Podcasts
Google Podcasts  ​​​​​
Spotify

From GAP 2018, Lorenzo Norris, MD, welcome Ashwin Patkar, MD, to discuss the opioid epidemic and how North Carolina is approaching it systemically. And later, Dr. RK knows that some of your patients are blue this time of year, she joins us to talk about what that is and what you can do about it.

In an evidence-based review, Dr. Patkar overviews the issue and includes dosages and references for FDA-approved buprenophine and burprenorphine/naloxone formulation. Click here to read that review.
Amazon Alexa
Apple Podcasts
Google Podcasts  ​​​​​
Spotify

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica